CVS Caremark to Present at the Raymond James 32nd Annual Institutional Investors Conference

WOONSOCKET, R.I., March 1, 2011 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced that Larry Merlo, President and Chief Executive Officer, and Dave Denton, Executive Vice President and Chief Financial Officer, will be making a presentation to investors at the Raymond James Annual Institutional Investors Conference on March 7, 2011.  Messrs. Merlo and Denton are scheduled to present at 11:00 am EST.

(Logo:  http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark Web site for all interested parties. To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the Web site for a one-year period following the presentation.

About CVS Caremark

CVS Caremark is the largest pharmacy health care provider in the United States with our integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health, and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including over 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com.

SOURCE CVS Caremark Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED